ITPR2

Chr 12AR

inositol 1,4,5-trisphosphate receptor type 2

Also known as: ANHD, CFAP48, INSP3R2, IP3R2

This gene encodes an inositol 1,4,5-trisphosphate receptor that functions as a calcium channel, transporting calcium from the endoplasmic reticulum to the cytoplasm in response to inositol trisphosphate binding. Autosomal recessive mutations cause isolated anhidrosis with normal sweat glands, indicating that this calcium signaling pathway is essential for eccrine sweat production. The gene shows moderate constraint against loss-of-function variants (LOEUF 0.615).

Summary from RefSeq, OMIM, UniProt
Research Assistant →

Primary Disease Associations & Inheritance

?Anhidrosis, isolated, with normal sweat glandsMIM #106190
AR
0
Active trials
17
Pubs (1 yr)
38
P/LP submissions
3%
P/LP missense
0.61
LOEUF
Multiple*
Mechanism· predicted
Clinical SummaryITPR2
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
38 unique Pathogenic / Likely Pathogenic· 262 VUS of 405 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Missense constrained — critical functional residues
LoF Constraint
0.61LOEUF
pLI 0.000
Z-score 5.45
OE 0.50 (0.420.61)
Tolerant

Typical tolerance to LoF variation

Missense Constraint
3.71Z-score
OE missense 0.72 (0.690.76)
1030 obs / 1423.9 exp
Constrained

Highly missense-constrained (top ~0.1%)

Observed / Expected Ratios
LoF OE0.50 (0.420.61)
00.351.4
Missense OE0.72 (0.690.76)
00.61.4
Synonymous OE1.03
01.21.6
LoF obs/exp: 71 / 140.7Missense obs/exp: 1030 / 1423.9Syn Z: -0.62
DN
0.6743th %ile
GOF
0.72top 25%
LOF
0.3065th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

405 submitted variants in ClinVar

Classification Summary

Pathogenic37
Likely Pathogenic1
VUS262
Likely Benign32
Benign20
Conflicting2
37
Pathogenic
1
Likely Pathogenic
262
VUS
32
Likely Benign
20
Benign
2
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
1
36
0
37
Likely Pathogenic
0
0
1
0
1
VUS
1
256
5
0
262
Likely Benign
0
10
5
17
32
Benign
0
1
6
13
20
Conflicting
2
Total12685330354

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

ITPR2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →